An Ethical Approach to Detecting Covert Consciousness
ConditionDisorder of Consciousness
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with prior or ongoing participation as subject in a research study using neurotechnologies for diagnosis and prognosis of disorders of consciousness (DoC) at Mass General Brigham
Patients capable of understanding and answering questions in English
Patients cble to provide informed consent
Patients for whom MRI / EEG are administered for clinical detection of consciousness and/or neuroprognostication
Disqualifiers
None
Trial population
Disorders of consciousness (DoC)
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Clinician Questionnaire
Other interventionSurveys will serve to identify preferences, expectations and concerns among clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through investigative neurotechnologies which will then be systematically evaluated.
Semi Structured Interviews
Other interventionSemi-structured interviews will further serve to identify preferences, expectations and concerns among patients, surrogates, clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through these investigative neurotechnologies which will then be systematically evaluated.
Treatment groups
70 Participants
are divided into 1 treatment groupGroup A: Use of advanced neurotechnologies to detect consciousness and predict recovery2 interventions
Trial outcomes
Primary outcomes
1
Surveys and semi-structured interviews
Capture and evaluate salient perspectives, preferences and values surrounding the use of advanced neurotechnologies to detect consciousness and predict recovery
Time frame
through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Massachusetts General Hospital
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov